We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gut Microbe Strains Linked to More Severe Strokes

By LabMedica International staff writers
Posted on 09 May 2022

The human microbiome is composed of bacteria, archaea, viruses and eukaryotic microbes that reside in and on individual bodies. More...

These microbes have tremendous potential to impact that physiology, both in health and in disease.

Globally, about 13 million people experience a stroke each year and about 5.5 million people die from strokes. A stroke happens when blood is not able to reach the brain. If blood flow to the brain becomes blocked, oxygen and vital nutrients cannot get to the brain, which can cause brain cells to die.

Medical Scientists at the Sant Pau Research Institute (Barcelona, Spain) and their colleagues have linked specific bacteria in the gut microbiome to both stroke severity and recovery. The team analyzed studied samples from 89 ischemic stroke patients and 12 controls. They performed shotgun metagenomics sequencing to analyze the taxonomic profiles.

The scientists identified multiple types of bacteria associated with an increased risk for ischemic stroke, including the bacteria Fusobacterium and Lactobacillus. They also found the bacteria Negativibacillus and Lentisphaeria were associated with a more severe stroke in the acute phase and the bacteria Acidaminococcus led to poor post-stroke recovery after three months.

Miquel Lledós, PhD, the lead author of the study, said, “Acidaminococcus is an opportunistic pathogen, and this genus has already been related to a higher risk of stroke.” Acidaminococcus is a member of the family Veillonellaceae, known for producing succinate, a compound linked to increased risk factors for cardiovascular disease.”

Dr. Lledós added, “In other pathologies, clinical trials are being carried out in which scientists replace the intestinal flora through dietary changes or fecal transplantation from healthy individuals that is much more consistent in the long term. One way to do that is by using lyophilized compounds of microorganisms in capsules that are easy to ingest and that modify the intestinal flora.”

The authors concluded that multiple new taxonomic profiles associated with stroke, revealing that gut microbiome could be an important factor associated with stroke risk and stroke acute and long-term outcome. The study was presented at the 2022 European Stroke Organisation Conference held May 4-6, 2022 in Lyon, France.

Related Links:
Sant Pau Research Institute 


Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.